Epilepsy affects about 50 million people worldwide, making it one of the most common neurological disorders. In India, nearly ...

Jackson Davis a six-year-old who has S.L.C.13A5 Epilepsy was granted a wish by the Make-A-Wish Foundation, and his sendoff ...

Neurona Therapeutics has circled up $102 million to push its off-the-shelf cell therapy for epilepsy through phase 3 testing.

Neurona will kick start a Phase III trial in H2 2025 investigating NRTX-1001 in patients with a type of drug-resistant ...

Raeley Shilling advocates for epilepsy awareness, sharing her personal experience with juvenile absence epilepsy in Plainfield, Indiana.

Childhood epilepsy is more than seizures. Learn to recognize symptoms, manage triggers, and support your child’s well-being.

Mar. 25, 2025 — A drug typically prescribed for arthritis halts brain-damaging seizures in mice that have a condition like epilepsy, according to researchers. If the drug proves viable for human ...

While generalized seizures cause convulsions, epilepsy includes other types like absence seizures (brief awareness lapses), ...

A real-world study supports cenobamate as an effective option for patients with drug-resistant epilepsy even after multiple ...

Tesla (T) magnetic resonance imaging changes management in more than half of adult candidates for epilepsy surgery.

A drug typically prescribed for arthritis halts brain-damaging seizures in mice that have a condition like epilepsy, ...

Neurona Therapeutics, a clinical-stage, privately-held, biotherapeutics company developing regenerative cell therapies for disorders of the nervous system, today announced the successful completion of ...